Head, Global Oncology Pipeline, Medical Affairs

*Hybrid 3x per week in Lake County, IL, Florham Park, NJ or San Francisco, CA. Purpose : • Lead global pipeline medical affairs strategy and develop compelling differentiation across the lifecycle, leveraging distinctive insights from the market to shape AbbVie TA pipeline​ • Shape initial value and evidence strategy and initiate Ev Gen plans, leveraging insights from payors, patients, and physicians​. Direct pipeline execution team, ensuring pull through of strategy to Enterprise Research MSLs​ • Collaborate with counterparts in International TAs, Global Therapeutic Area BU and Development​ • Represent TA in pipeline governance, where aligned with TA BU Head​ • Interface with Operations and Medical Engagement teams to operationalize pipeline strategy Responsibilities : • Lead and oversee pipeline (including BD) medical, value and evidence strategy development across all disease areas within TA to serve both US and International markets for all indications/ brands up to 24-36 months pre-launch (in any geography)​ • Drive compelling differentiation of medical, value and evidence strategy from discovery, leveraging distinctive insights from US and International markets​ • Coordinate across TAs to ensure that TA-level pipeline strategies coalesce into a coherent AbbVie pipeline strategy​ • Ensure HCP, Patients and Payor insights are incorporated into the developments programs to accelerate and differentiate clinical and commercialization strategies (e.g., streamlined patient data collection, patient finding) ​ • Co-create the Brand strategy for all assets and ensure US and International market insights are embedded in the brand strategy​ • Represent medical affairs in pipeline-related governance, serving as the single point of contact for commercial and development counterparts ​ • Serve as final decision maker (pre-BU head) for all pipeline-related strategy and decisions​ • Manage pipeline resources effectively, redirecting pipeline team to enterprise critical assets along the lifecycle as needed, starting as early as discovery​ • Ensure effective handover to US and International inline/ launch teams, onboarding with relevant TAs to share insights/ approach/ etc. from pipeline strategy efforts and minimizing duplication of effort across pipeline and inline teams​ • Lead cross-functional gap assessment and Integrated Evidence Planning (IEP) and collaborate with Value and Evidence • Define strategy for enterprise research MSLs in US and affiliates, leveraging pipeline insights to develop priorities and shape tactical plans​ • Coordinate with pipeline execution group in US Medical Engagement to drive execution​ • Collaborate with US Medical Engagement to track impact-focused KPIs and re-shape pipeline strategy based on impact or best practices​ • M.D., or equivalent advanced degree in a relevant scientific discipline (e.g., oncology/hematology) • 15+ years of experience in the pharmaceutical or biotechnology industry, with a focus on oncology, specifically hematology • Demonstrated expertise in clinical development, regulatory requirements, and commercialization of oncology therapies • Proven leadership experience in medical affairs, including managing direct and indirect reports, cross-functional teams and influencing strategic direction at the senior executive level • Strong scientific knowledge of solid tumor biology, clinical trial design, biomarker development, and emerging treatment modalities (e.g., immuno-oncology, targeted therapies, precision medicine) • Proven ability to work cross-functionally and collaborate effectively with clinical development, regulatory, commercial, and other business functions • Exceptional communication skills, with experience presenting complex scientific information to bot